"Neuromuscular Blockade" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here.
| Descriptor ID |
D019148
|
| MeSH Number(s) |
E03.706 E05.635
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neuromuscular Blockade".
Below are MeSH descriptors whose meaning is more specific than "Neuromuscular Blockade".
This graph shows the total number of publications written about "Neuromuscular Blockade" by people in this website by year, and whether "Neuromuscular Blockade" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2017 | 6 | 0 | 6 |
| 2018 | 1 | 2 | 3 |
| 2019 | 6 | 2 | 8 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Neuromuscular Blockade" by people in Profiles.
-
Fixed dilated pupils in Covid-19 ARDS patients under rocuronium, reversed after discontinuation. J Crit Care. 2021 10; 65:259-260.
-
Neuromuscular blockade management in patients with COVID-19. Korean J Anesthesiol. 2021 08; 74(4):285-292.
-
Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities. J Trauma Acute Care Surg. 2021 05 01; 90(5):880-890.
-
Consensus for the management of analgesia, sedation and delirium in adults with COVID-19-associated acute respiratory distress syndrome. Rev Bras Ter Intensiva. 2021 Jan-Mar; 33(1):48-67.
-
Management of Respiratory Distress Syndrome due to COVID-19 infection. BMC Anesthesiol. 2020 07 20; 20(1):177.
-
Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results? Crit Care. 2019 09 06; 23(1):305.
-
Bispectral Index for Titrating Sedation in ARDS Patients During Neuromuscular Blockade. Am J Crit Care. 2019 09; 28(5):377-384.
-
The role of sugammadex, a novel cyclodextrin compound in modern anesthesia practice: conventional neuromuscular physiology and clinical pharmacology. Expert Rev Clin Pharmacol. 2019 Oct; 12(10):917-919.
-
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med. 2019 08 22; 381(8):786-787.
-
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. Reply. N Engl J Med. 2019 08 22; 381(8):787-788.